Avalon GloboCare announced that Laboratory Services MSO has launched a direct-to-consumer and non-invasive DNA test in the U.S. that tests for potential predisposition to opioid dependence.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALBT:
- Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
- Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us
- Avalon announces launch of online sales for KetoAir breathalyzer device
- Avalon GloboCare Launches KetoAir™ Breathalyzer in U.S. Market
- Avalon provides update on KetoAir Breathalyzer launch